Heart Failure Clinical Trials
148 studies are recruiting for heart failure in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 6
-
A Nurse-Led Weight Monitoring Intervention For Heart Failure Quality of LIfe and Self-Care
Ongoing self-care for heart failure is essential to avoid complications and hospitalization. Supportive strategies are needed; however, patients with heart failure may find many interventions complicated and overwhelming. The purpose of this pilot study is to implement a simple weight tracking tool…
- Stage
- Not phased
- Ages
- 55 and older
- Site
- Cleveland Clinic Avon Hospital, Avon, Ohio
- Run by
- Lee Anne Siegmund
-
TEXT4HF: A Randomized Controlled Trial of a Tailored Text Messaging Intervention to Improve Self-Care in Older Adult Patients With Heart Failure
The goal of this study is to determine whether an individually tailored text messaging intervention can improve self-care in older adult patients with heart failure. The main question it aims to answer are: * Is a tailored text messaging intervention feasible and acceptable among older adult patien…
- Stage
- Not phased
- Ages
- 50 and older
- Site
- University of Illinois, Chicago, Chicago, Illinois
- Run by
- University of Illinois at Chicago
-
UIC Multi-Ethnic DCM Registry
Dilated cardiomyopathy (DCM), a condition where the heart loses its ability to pump blood throughout the body, is a common cause of death in the United States (US). It affects minorities more frequently and appears to causes greater harm than Whites. However, almost all research related to DCM has …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Illinois Hospital & Health Sciences, Chicago, Illinois
- Run by
- University of Illinois at Chicago
-
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
Developed nations worldwide are currently enduring a health crisis, as chronic diseases continue to decrease quality of life and promote additional disease states or even death for much of the population. Rural populations are at a particular disadvantage, as they lack access to health clubs, welln…
- Stage
- Not phased
- Ages
- 18 to 64
- Site
- West Virginia School of Osteopathic Medicine, Lewisburg, West Virginia
- Run by
- West Virginia School of Osteopathic Medicine
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
The aim of this study is to evaluate feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. Several components will be assessed such as quality-of-life, nutritional counseling, maximum metabolic activity (MET's), diabetic management, tobacco …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- ROMTech, Brookfield, Connecticut
- Run by
- ROM Technologies, INC
-
A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System
The objective of this study is to evaluate the safety and performance of the V-LAP System in subjects with New York Heart Association (NYHA) functional class II and III HF, irrespective of left ventricular ejection fraction.
- Stage
- Not phased
- Ages
- 22 to 88
- Site
- One Boston Medical Center Place, Boston, Massachusetts
- Run by
- Vectorious Medical Technologies Ltd.
-
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
This study aims to determine, via skeletal muscle ultrasound (US), the extent, timing and relationship between skeletal muscle mass loss and outcomes after orthotropic heart transplantation (OHT) and left ventricular assist device (LVAD) implantation amongst patients with cardiogenic shock. Advance…
- Stage
- Not phased
- Ages
- 18 to 100
- Site
- Tufts Medical Center, Boston, Massachusetts
- Run by
- Tufts Medical Center
-
Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues
Magnetic resonance elastography is a novel non-invasive MRI technique to obtain stiffness of soft tissues such as liver, heart, kidneys, etc. In this imaging technique a person is laid in an MR scanner and a paddle (plastic drum) is put on the area of interest to send sound vibration via a speaker …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- The Ohio State University Wexner Medical Center, Columbus, Ohio
- Run by
- Arunark Kolipaka
-
Studies of Neuregulin/ERBB Signaling in Human Heart
This study examines the role of the epidermal growth factor (EGF) receptor family and the EGF family of ligands in the regulation of non-myocytes isolated from the human heart.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Maine Medical Center, Portland, Maine
- Run by
- Douglas B. Sawyer
-
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively analyzed to determine the sensitivity and UPNR of the HearO system.
- Stage
- Not phased
- Ages
- 22 and older
- Site
- Eastern Shore Research Institute, Fairhope, Alabama
- Locations
- 45 in total
- Run by
- Cordio Medical
-
Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement
The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Oregon Health & Science University, Portland, Oregon
- Run by
- Oregon Health and Science University
-
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
This is a prospective, single-arm clinical trial in which participants with dilated cardiomyopathy will invite their first degree relatives to undergo mobile cardiac, electrocardiogram screening.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Lancaster General Hospital, Lancaster, Pennsylvania
- Run by
- Lancaster General Hospital
-
Get With The Guidelines-Heart Failure Registry
Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.
- Stage
- Not phased
- Ages
- 18 to 125
- Site
- Amy Bennett, Dallas, Texas
- Run by
- American Heart Association
-
Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart Failure
Anthracycline chemotherapies (e.g. doxorubicin, daunorubicin) are commonly given to treat pediatric cancer, and carry a risk of cardiotoxicity. Over the long term, children who receive these therapies have an increased risk of heart failure and early cardiovascular death. However, current strategie…
- Stage
- Not phased
- Ages
- 13 to 39
- Site
- Rady Children's Hospital, San Diego, California
- Run by
- Hari Narayan
-
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
- Stage
- Not phased
- Ages
- 20 to 90
- Site
- UT Southwestern Medical Center, Dallas, Texas
- Locations
- 3 in total
- Run by
- Brigham and Women's Hospital
-
BiVACOR® Total Artificial Heart Early Feasibility Study
The purpose of this study is to assess the feasibility of using the BiVACOR Total Artificial Heart (TAH) System to support adult patients with severe biventricular heart failure, or univentricular heart failure in which left ventricular assist device (LVAD) support is not recommended, who require m…
- Stage
- Not phased
- Ages
- 18 to 70
- Site
- Banner - University Medical Center Phoenix, Phoenix, Arizona
- Locations
- 4 in total
- Run by
- BiVACOR Inc.
-
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulato…
- Stage
- Not phased
- Ages
- 18 to 100
- Site
- Scripps Health, La Jolla, California
- Locations
- 12 in total
- Run by
- University of Kansas Medical Center
-
Colchicine in Acutely Decompensated HFREF
This is a double blind, placebo-controlled pilot trial randomizing patients admitted to the hospital with acutely decompensated heart failure (ADHF) and inflammation to receive either colchicine or matching placebo. Upon enrollment, patients will be randomized 1:1 to receive either the experimental…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- UVA Health, Charlottesville, Virginia
- Run by
- University of Virginia
-
Implantable Cardioverter Defibrillator (ICD Registry)
The ICD Registry™ is a nationwide quality program that helps participating hospitals measure and improve care for patients receiving implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices with defibrillator (CRT-Ds). The ICD Registry captures the characteristic…
- Stage
- Not phased
- Ages
- Any age
- Site
- American College of Cardiology/National Cardiovascular Data Registry (NCDR), Washington D.C., District of Columbia
- Run by
- American College of Cardiology
-
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
It is believed that targeted SERCA2a enzyme replacement in HFrEF patients will correct defective intracellular Ca2+ hemostasis, resulting in improved cardiac contractile function and energetics which will, in turn, translate to improved clinical outcomes. Additionally, it is hypothesized that corre…
- Stage
- Phase 1
- Ages
- 18 to 80
- Site
- San Diego Cardiac Center, San Diego, California
- Locations
- 5 in total
- Run by
- Sardocor Corp.
-
Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
Heart failure is a syndrome that is defined by distinctive clinical, hemodynamic, and neurohormonal findings. HF represents a final common pathway for many different cardiovascular diseases, including coronary disease, hypertension, Valvular disease, and many primary heart muscle diseases. Clinical…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Multiple Locations, Phoenix, Arizona
- Run by
- Aventyn, Inc.
-
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
This is an international prospective, multicentre, unblinded, randomised-controlled trial. The primary aim is to assess a targeted screening strategy to detect undiagnosed heart failure in high-risk patients.
- Stage
- Not phased
- Ages
- 40 and older
- Site
- University of Glasgow, Glasgow, Scotland
- Locations
- 7 in total
- Run by
- NHS Greater Glasgow and Clyde
-
Use of ReDS Technology in Patients With Acute Heart Failure
Background: Fluid overload, especially pulmonary congestion, is one of the main contributors into heart failure (HF) readmission risk and it is a clinical challenge for clinicians. The Remote dielectric sensing (ReDS) system is a novel electromagnetic energy-based technology that can accurately qua…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mount Sinai Hospital, New York, New York
- Run by
- Icahn School of Medicine at Mount Sinai
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.